ANTITUMOR
ANTITUMOR
Our research group has a number of potential antitumor inhibitors of cytochromes (CYP17A1 and CYP19A1) and BCR-ABL tyrosine kinases developed by in silico methods.
Our research group has a number of potential antitumor inhibitors of cytochromes (CYP17A1 and CYP19A1) and BCR-ABL tyrosine kinases developed by in silico methods.